144 related articles for article (PubMed ID: 10665643)
1. Reduced T cell response in carcinogen-sensitive Donryu rats compared with carcinogen-resistant DRH rats.
Mise-Omata S; Sugiura T; Higashi K; Yamashita U
Jpn J Cancer Res; 1999 Dec; 90(12):1277-84. PubMed ID: 10665643
[TBL] [Abstract][Full Text] [Related]
2. Different responses other than the formation of DNA-adducts between the livers of carcinogen-resistant rats (DRH) and carcinogen-sensitive rats (Donryu) to 3'-methyl-4-dimethylaminoazobenzene administration.
Yan Y; Higashi K; Yamamura K; Fukamachi Y; Abe T; Gotoh S; Sugiura T; Hirano T; Higashi T; Ichiba M
Jpn J Cancer Res; 1998 Aug; 89(8):806-13. PubMed ID: 9765615
[TBL] [Abstract][Full Text] [Related]
3. Blunt cell growth potential in carcinogen resistant inbred DRH rats.
Yamashiro K; Yan Y; Fukamachi Y; Gotoh S; Higashi K; Ohtsuki M; Hamada Y; Higashi T
Exp Anim; 2000 Jan; 49(1):47-50. PubMed ID: 10803362
[TBL] [Abstract][Full Text] [Related]
4. Remarkable difference in the incidence of liver tumors by N-nitrosodimethylamine in carcinogen-resistant DRH rat and its parental strain Donryu rat.
Yan Y; Higashi K; Tanimoto A; Fukamachi Y; Itoh H; Abe T; Higashi T
J UOEH; 1998 Dec; 20(4):307-14. PubMed ID: 9883481
[TBL] [Abstract][Full Text] [Related]
5. Investigation of possible involvement of several genes related to development of hepatocarcinogenesis in rats.
Todaka N; Higashi K; Yan Y; Abe T; Yamashiro K; Hiai H
J UOEH; 2000 Jun; 22(2):119-32. PubMed ID: 10862407
[TBL] [Abstract][Full Text] [Related]
6. Genetic properties for the suppression of development of putative preneoplastic glutathione S-transferase placental form-positive foci in the liver of carcinogen-resistant DRH strain rats.
Denda A; Kitayama W; Konishi Y; Yan Y; Fukamachi Y; Miura M; Gotoh S; Ikemura K; Abe T; Higashi T; Higashi K
Cancer Lett; 1999 Jun; 140(1-2):59-67. PubMed ID: 10403542
[TBL] [Abstract][Full Text] [Related]
7. Role of resistant Drh1 locus in chemical carcinogen-induced hepatocarcinogenesis in rats: analysis with a speed congenic strain.
Liu H; Higashi K; Hiai H
Cancer Sci; 2005 Mar; 96(3):164-9. PubMed ID: 15771619
[TBL] [Abstract][Full Text] [Related]
8. Studies on the microsomal cytochrome P450s in the livers of carcinogen-resistant and sensitive rats during long-term administration of 3'-methyl-4-dimethylaminoazobenzene.
Yang M; Yamamura K; Yan Y; Fukamachi Y; Hirano T; Kawamoto T; Higashi K
J UOEH; 1997 Dec; 19(4):277-86. PubMed ID: 9431579
[TBL] [Abstract][Full Text] [Related]
9. Immunotoxicity of 2,4-diaminotoluene in female B6C3F1 mice.
Burns LA; Bradley SG; White KL; McCay JA; Fuchs BA; Stern M; Brown RD; Musgrove DL; Holsapple MP; Luster MI
Drug Chem Toxicol; 1994; 17(3):401-36. PubMed ID: 7988388
[TBL] [Abstract][Full Text] [Related]
10. Genetic resistance to chemical hepatocarcinogenesis in the DRH rat strain.
Higashi K; Denda A; Higashi T; Hiai H
Comp Med; 2004 Aug; 54(4):373-7. PubMed ID: 15357316
[TBL] [Abstract][Full Text] [Related]
11. Low p38 MAPK and JNK activation in cultured hepatocytes of DRH rats; a strain highly resistant to hepatocarcinogenesis.
Honmo S; Ozaki A; Yamamoto M; Hashimoto N; Miyakoshi M; Tanaka H; Yoshie M; Tamakawa S; Tokusashi Y; Yaginuma Y; Kasai S; Ogawa K
Mol Carcinog; 2007 Sep; 46(9):758-65. PubMed ID: 17546627
[TBL] [Abstract][Full Text] [Related]
12. A predictive F344 rat immunotoxicology model: cellular parameters combined with humoral response to NP-CgammaG and KLH.
Smith HW; Winstead CJ; Stank KK; Halstead BW; Wierda D
Toxicology; 2003 Dec; 194(1-2):129-45. PubMed ID: 14636702
[TBL] [Abstract][Full Text] [Related]
13. Low selection of preneoplastic hepatocytes after treatment with the 2-acetylaminofluorene diet-partial hepatectomy regimen in the liver of hepatocarcinogenesis-resistant DRH strain rats.
Imai K; Yamamoto M; Tanaka H; Hashimoto N; Miyakoshi M; Honmou S; Yoshie M; Tamakawa S; Yaginuma Y; Kasai S; Ogawa K
Oncol Rep; 2007 Jan; 17(1):55-60. PubMed ID: 17143478
[TBL] [Abstract][Full Text] [Related]
14. Studies on the multidrug resistance gene expression in the livers of rats associated with different susceptibility of hepatocarcinogenesis.
Gotoh S; Todaka N; Yan Y; Fukamachi Y; Abe T; Higashi K
J UOEH; 1999 Dec; 21(4):265-76. PubMed ID: 10629898
[TBL] [Abstract][Full Text] [Related]
15. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B cell interactions.
Van den Eertwegh AJ; Noelle RJ; Roy M; Shepherd DM; Aruffo A; Ledbetter JA; Boersma WJ; Claassen E
J Exp Med; 1993 Nov; 178(5):1555-65. PubMed ID: 7693849
[TBL] [Abstract][Full Text] [Related]
16. The paradoxical effects of lead in interferon-gamma knockout BALB/c mice.
Gao D; Kasten-Jolly J; Lawrence DA
Toxicol Sci; 2006 Feb; 89(2):444-53. PubMed ID: 16280381
[TBL] [Abstract][Full Text] [Related]
17. Genetic resistance to chemical carcinogen-induced preneoplastic hepatic lesions in DRH strain rats.
Zeng ZZ; Higashi S; Kitayama W; Denda A; Yan Y; Matsuo K; Konishi Y; Hiai H; Higashi K
Cancer Res; 2000 Jun; 60(11):2876-81. PubMed ID: 10850431
[TBL] [Abstract][Full Text] [Related]
18. Improvement and optimization of a T-cell-dependent antibody response (TDAR) method for BALB/c mice using keyhole limpet hemocyanin (KLH) as specific antigen.
Chang P; Huang L; Huang M; Tian S; Yang Z
J Immunotoxicol; 2019 Dec; 16(1):149-154. PubMed ID: 31290717
[TBL] [Abstract][Full Text] [Related]
19. IL-4 synthesis by in vivo primed keyhole limpet hemocyanin-specific CD4+ T cells. I. Influence of antigen concentration and antigen-presenting cell type.
DeKruyff RH; Fang Y; Umetsu DT
J Immunol; 1992 Dec; 149(11):3468-76. PubMed ID: 1358971
[TBL] [Abstract][Full Text] [Related]
20. Effect of immunological adjuvant combinations on the antibody and T-cell response to vaccination with MUC1-KLH and GD3-KLH conjugates.
Kim SK; Ragupathi G; Cappello S; Kagan E; Livingston PO
Vaccine; 2000 Oct; 19(4-5):530-7. PubMed ID: 11027818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
